Nanodrugs have been around for some time. In fact, over 250 drugs using nanotechnology that have been approved by the FDA and are in clinical use. The name nanodrug or nanopharmaceuticals refers to the size of the particle that is created to house the medication. A nano is very tiny: nanoparticles are between 1 and 100 nanometers in at least one of its...
Read More
Around one million people in the US have Parkinson’s disease. In Parkinson’s, the dopamine-producing cells of the brain–in an area called the substantia nigra–die off. Abnormal proteins are what kill these brain cells. In fact, all neurodegenerative diseases have deposits of abnormal proteins, and neurobiologists call them...
Read More
In 2005, a research review article on the blood-brain barrier stated, “The blood-brain barrier (BBB) is the bottleneck in brain drug development and is the single most important factor limiting the future growth of neurotherapeutics.” By 2016, researchers have been able to state that “Ongoing advances in delivery approaches that overcome...
Read More
